Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: J Subst Abuse Treat. 2020 Jun 15;117:108058. doi: 10.1016/j.jsat.2020.108058

Table 2:

Multivariate logistic regression models of factors associated with willingness to use LAI-PrEP (N=234).

Variables Willingness to use LAI-PrEP c
aOR c 95% CI d P

Sex
 Male Ref - -
 Female 2.181 1.144, 4.159 0.018
Visited healthcare provider (last 12 months) a
 No Ref - -
 Yes 2.919 1.156, 7.370 0.023
Perceived risk of HIV transmission
 Low Ref - -
 High 3.255 1.372, 7.721 0.007
Heard of oral PrEPb
 No Ref - -
 Yes 1.202 0.618, 2.340 0.588
Ever used oral PrEP
 No Ref - -
 Yes 3.284 1.242, 8.684 0.017

R2 = 0.180

Hosmer and Lemeshow Test: Chi-square = 3.079; p = 0.929

Note:

a

in the past 12 months;

b

PrEP: pre-exposure prophylaxis;

c

LAI-PrEP: long-acting injectable PrEP;

d

aOR: adjusted odds ratio;

e

CI: confidence interval